124 related articles for article (PubMed ID: 22064563)
1. Medication utilization for targeted symptoms in children and adults with fragile X syndrome: US survey.
Bailey DB; Raspa M; Bishop E; Olmsted M; Mallya UG; Berry-Kravis E
J Dev Behav Pediatr; 2012 Jan; 33(1):62-9. PubMed ID: 22064563
[TBL] [Abstract][Full Text] [Related]
2. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder.
Visser SN; Lesesne CA; Perou R
Pediatrics; 2007 Feb; 119 Suppl 1():S99-106. PubMed ID: 17272592
[TBL] [Abstract][Full Text] [Related]
3. The behavioral phenotype of FMR1 mutations.
Boyle L; Kaufmann WE
Am J Med Genet C Semin Med Genet; 2010 Nov; 154C(4):469-76. PubMed ID: 20981777
[TBL] [Abstract][Full Text] [Related]
4. Anxiety, attention problems, hyperactivity, and the Aberrant Behavior Checklist in fragile X syndrome.
Wheeler A; Raspa M; Bann C; Bishop E; Hessl D; Sacco P; Bailey DB
Am J Med Genet A; 2014 Jan; 164A(1):141-55. PubMed ID: 24352914
[TBL] [Abstract][Full Text] [Related]
5. Therapy service use among individuals with fragile X syndrome: findings from a US parent survey.
Martin GE; Ausderau KK; Raspa M; Bishop E; Mallya U; Bailey DB
J Intellect Disabil Res; 2013 Sep; 57(9):837-49. PubMed ID: 22974130
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
7. Fragile X syndrome: a psychiatric perspective.
Tranfaglia MR
Results Probl Cell Differ; 2012; 54():281-95. PubMed ID: 22009359
[TBL] [Abstract][Full Text] [Related]
8. [Can the behavioural phenotype of fragile X syndrome be attributed to mental retardation and to attention deficit hyperactivity disorder?].
Artigas-Pallarés J; Brun-Gasca C
Rev Neurol; 2004 Jan 1-15; 38(1):7-11. PubMed ID: 14730483
[TBL] [Abstract][Full Text] [Related]
9. Self-injurious behavior and fragile X syndrome: findings from the national fragile X survey.
Symons FJ; Byiers BJ; Raspa M; Bishop E; Bailey DB
Am J Intellect Dev Disabil; 2010 Nov; 115(6):473-81. PubMed ID: 20946000
[TBL] [Abstract][Full Text] [Related]
10. The psychiatric presentation of fragile x: evolution of the diagnosis and treatment of the psychiatric comorbidities of fragile X syndrome.
Tranfaglia MR
Dev Neurosci; 2011; 33(5):337-48. PubMed ID: 21893938
[TBL] [Abstract][Full Text] [Related]
11. Psychotropic Drug Treatment Patterns in Persons with Fragile X Syndrome.
Dominick KC; Andrews HF; Kaufmann WE; Berry-Kravis E; Erickson CA
J Child Adolesc Psychopharmacol; 2021 Dec; 31(10):659-669. PubMed ID: 34818076
[No Abstract] [Full Text] [Related]
12. Overweight in children and adolescents in relation to attention-deficit/hyperactivity disorder: results from a national sample.
Waring ME; Lapane KL
Pediatrics; 2008 Jul; 122(1):e1-6. PubMed ID: 18595954
[TBL] [Abstract][Full Text] [Related]
13. Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder--United States, 2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(34):842-7. PubMed ID: 16138075
[TBL] [Abstract][Full Text] [Related]
14. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM; Earls MF
Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
[TBL] [Abstract][Full Text] [Related]
15. Does connection to primary care matter for children with attention-deficit/hyperactivity disorder?
Toomey SL; Finkelstein J; Kuhlthau K
Pediatrics; 2008 Aug; 122(2):368-74. PubMed ID: 18676555
[TBL] [Abstract][Full Text] [Related]
16. Seizures in fragile X syndrome: characteristics and comorbid diagnoses.
Berry-Kravis E; Raspa M; Loggin-Hester L; Bishop E; Holiday D; Bailey DB
Am J Intellect Dev Disabil; 2010 Nov; 115(6):461-72. PubMed ID: 20945999
[TBL] [Abstract][Full Text] [Related]
17. Health and economic consequences of fragile X syndrome for caregivers.
Bailey DB; Raspa M; Bishop E; Mitra D; Martin S; Wheeler A; Sacco P
J Dev Behav Pediatr; 2012; 33(9):705-12. PubMed ID: 23117595
[TBL] [Abstract][Full Text] [Related]
18. Sleep problems in children with attention-deficit/hyperactivity disorder: prevalence and the effect on the child and family.
Sung V; Hiscock H; Sciberras E; Efron D
Arch Pediatr Adolesc Med; 2008 Apr; 162(4):336-42. PubMed ID: 18391142
[TBL] [Abstract][Full Text] [Related]
19. Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children --- United States, 2003 and 2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 Nov; 59(44):1439-43. PubMed ID: 21063274
[TBL] [Abstract][Full Text] [Related]
20. Review of medication adherence in children and adults with ADHD.
Adler LD; Nierenberg AA
Postgrad Med; 2010 Jan; 122(1):184-91. PubMed ID: 20107302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
